Apotea

Apotea is poised for growth with its online pharmacy dominance and upcoming market expansions

Unike

Invested

Community Contributor

Published

10 Mar 25

Updated

18 Mar 25

Unike's Fair Value

SEK 94.41

17.8% overvalued

18 Mar

SEK 111.26

n/a

-2.0%

Author's Valuation

SEK 94.4

17.8% overvalued

Unike's Fair Value

Narrative

Updates0

Unike'sFair Value

SEK 94.4

17.8% overvalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

13.64%

Food and Staples Retail revenue growth rate

0.17%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

4.92%

Calculation

SEK 458.71m

Earnings '30

30.00x

PE Ratio '30

SEK 13.76b

Market Cap '30

SEK 13.76b

Market Cap '30

110.97m

No. shares '30

SEK 124.01

Share Price '30

SEK 124.01 Share Price '30

Discounted to 2025 @ 4.76% p.a.

SEK 98.26

Fair Value '25